info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_SKIN_FACE_EXALLC for full statistics.

Carcinoma in situ of skin of other and unspecified parts of face

CD2_INSITU_SKIN_FACE

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D04.3&
  • Hospital discharge: ICD-9 2323
  • Cause of death: ICD-10 D04.3&
  • Cause of death: ICD-9 2323

2 out of 7 registries used, show all original rules.

2801

4. Check minimum number of events

None

2801

5. Include endpoints

None

2801

6. Filter based on genotype QC (FinnGen only)

2801

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D04
Name in latin
Carcinoma in situ cutis faciei

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 2801 1358 1443
Unadjusted period prevalence (%) 0.55 0.46 0.64
Median age at first event (years) 76.94 76.79 77.08

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2428
Matched controls
24278
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
19.5
323.0
1372
1512
ZXC50
NOMESCO Finland
Cryotherapy
16.4
323.0
610
486
R23.8
ICD-10 Finland
Other and unspecified skin changes
7.3
323.0
1053
2295
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
20.8
323.0
567
350
TQW99
NOMESCO Finland
Other minor procedure on skin
19.3
323.0
906
724
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
10.1
323.0
900
1333
L57.0
ICD-10 Finland
Actinic keratosis
37.1
323.0
1873
2021
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
13.1
323.0
1150
1564
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4503599627370496.0
323.0
2423
15
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
30.8
318.2
432
169
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
16.1
289.1
492
378
ZXC20
NOMESCO Finland
Use of chemical agents
18.9
272.3
433
276
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
21.3
266.0
404
225
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
8.5
247.0
597
899
ZXC15
NOMESCO Finland
Use of photodynamic technique
21.2
222.6
338
184
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
10.4
196.9
411
467
D06BB10
ATC
imiquimod; topical
9.1
192.1
433
563
S18
ICPC
Laceration/cut
3.6
187.5
1551
8065
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
36.7
179.9
233
70
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
27.7
161.9
225
89
ZQZ00
NOMESCO Finland
Treatment of several skin areas
32.5
148.7
198
66
ZZR00
NOMESCO Finland
Flap of skin
10.0
148.4
313
354
L82
ICD-10 Finland
Seborrhoeic keratosis
3.9
147.8
740
2444
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
6.3
132.3
381
692
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
31.0
130.7
176
61
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
4.8
128.5
485
1205
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
11.8
121.7
233
216
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.2
121.1
412
910
Z2221
NOMESCO Finland
Medical doctor
2.9
119.0
981
4558
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
10.5
99.1
201
207
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
7.3
93.4
237
354
XQ848
NOMESCO Finland
Dermatological photography
8.1
90.9
214
285
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
20.1
88.4
135
71
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
30.9
87.9
118
40
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
8.0
86.7
206
278
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
11.6
86.5
166
153
ZXE00
NOMESCO Finland
One hour or less
2.3
84.3
1167
6862
SPAT1153
SPAT
Removal of sutures
2.4
83.3
1074
6082
A98
ICPC
Health maint/preventive medicine
3.5
83.1
2232
18530
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
81.9
1189
7121
D06BX02
ATC
ingenol mebutate; topical
9.3
80.8
174
199
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
8.9
80.8
179
215
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
78.0
1114
6565
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
33.9
77.1
101
31
S29
ICPC
Skin symptom/complaint other
2.7
76.2
619
2698
DHB00
NOMESCO Finland
Excision of lesion of external nose
12.8
76.1
139
115
127
Kela drug reimbursment
Transplant complication
17.3
76.0
122
74
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
15.2
72.8
123
85
WX110
NOMESCO Finland
Local anesthesy
2.2
70.4
1544
10843
S21
ICPC
Skin texture symptom/complaint
2.9
69.3
483
1899
Z3231
NOMESCO Finland
Registered nurse
2.3
68.0
885
4901
R4110
NOMESCO Finland
Physiotherapy
2.3
65.8
821
4439
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
10.9
65.7
129
124
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
10.3
64.1
130
133
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
18.6
61.0
95
53
Z94.0
ICD-10 Finland
Kidney transplant status
16.2
57.4
94
60
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
14.3
56.9
98
71
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
5.1
55.5
184
382
J01DB01
ATC
cefalexin; oral
2.1
54.4
1920
15482
L04AA06
ATC
mycophenolic acid; systemic
11.7
52.9
100
89
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
17.3
52.7
84
50
E0000UV
ATC
NA
2.0
52.7
996
6283
WX002
NOMESCO Finland
Sedation and analgesia
2.2
52.5
663
3528
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.2
51.9
168
339
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
16.0
51.7
85
55
TQW80
NOMESCO Finland
Local dermatologic skincare
5.7
51.5
154
283
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
21.8
50.3
74
35
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
42.3
49.9
62
15
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.9
49.1
170
370
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.9
48.6
166
356
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
30.3
48.5
65
22
S77
ICPC
Malignant neoplasm of skin
7.7
48.3
116
158
L04AD01
ATC
ciclosporin; systemic
9.5
48.2
101
110
Z3226
NOMESCO Finland
Physiotherapist
2.2
47.7
579
3007
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
17.0
47.4
76
46
ZZA00
NOMESCO Finland
Split skin graft
4.4
45.9
177
429
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
5.4
45.7
144
282
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
12.8
45.1
81
65
DAB10
NOMESCO Finland
Partial excision of auricle
13.8
42.6
74
55
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
9.6
42.2
88
95
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
14.2
42.0
72
52
DAB00
NOMESCO Finland
Excision of lesion of auricle
8.4
41.2
93
115
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
40.4
1185
8453
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
39.0
620
3561
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
38.7
470
2414
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
11.6
38.3
72
64
L04AA01
ATC
[U] ciclosporin; systemic
7.8
36.6
86
114
N02BE01
ATC
paracetamol; systemic, rectal
2.0
34.7
2087
18263
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
28.1
34.7
47
17
ZXA05
NOMESCO Finland
Left side
1.8
34.5
789
5115
ZXA00
NOMESCO Finland
Right side
1.8
34.4
821
5398
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.6
34.4
125
286
TQW40
NOMESCO Finland
Remowal of suture of skin
2.9
33.4
216
787
QAE99
SPAT
NA
11.8
32.9
61
53
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
32.3
1233
9270
XQ845
NOMESCO Finland
Dermatoscopy
6.2
32.0
88
146
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
31.9
674
4235
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
31.5
205
749
S26
ICPC
Fear of cancer of skin
6.4
31.3
84
135
D07AB08
ATC
desonide; topical
2.3
31.2
306
1409
ZZA50
NOMESCO Finland
Full thickness skin graft
8.7
31.2
68
80
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
8.4
31.0
69
84
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
31.0
492
2791
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
14.9
30.5
51
35
A12AA04
ATC
calcium carbonate; oral
5.6
30.0
90
167
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
3.8
29.0
126
341
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
19.9
28.7
43
22
S82
ICPC
Naevus/mole
2.2
28.6
326
1610
WX320
NOMESCO Finland
Spinalanesthesy
1.8
28.5
625
3953
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
28.3
381
2017
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
12.1
28.0
51
43
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
8.5
27.8
61
73
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
27.5
594
3730
Z71.8
ICD-10 Finland
Other specified counselling
1.9
27.4
504
3002
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.1
27.1
108
271
B07.9
ICD-10 Finland
Verruca simplex
4.4
27.0
100
234
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
26.4
173
635
K02.1
ICD-10 Finland
Caries of dentine
1.6
25.9
992
7305
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
25.7
1280
10062
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
25.6
162
581
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
5.5
25.6
77
144
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
12.3
25.5
46
38
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
11.4
25.1
47
42
S08
ICPC
Skin colour change
2.7
25.0
184
725
TQW40
SPAT
NA
3.9
24.9
105
277
J01CA04
ATC
amoxicillin; systemic
1.6
24.9
1700
14385
L04AX01
ATC
azathioprine; systemic
3.5
24.9
119
349
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
24.7
1125
8614
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.4
24.7
59
81
L17
ICPC
Foot/toe symptom/complaint
1.7
24.7
650
4312
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
7.2
24.6
60
85
D07AC01
ATC
betamethasone; topical
1.6
24.6
791
5547
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
13.8
24.5
42
31
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
16.5
24.5
39
24
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
24.2
1702
14447
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
23.7
968
7197
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.1
23.5
135
455
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
23.3
398
2296
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
13.5
23.2
40
30
D04
ICD-10 Finland
Carcinoma in situ of skin
54.5
23.1
27
5
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
6.4
22.9
61
98
B01AB05
ATC
enoxaparin; parenteral
1.6
22.5
812
5831
A11CC03
ATC
alfacalcidol; systemic
3.7
22.5
100
277
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
22.4
793
5669
A02BC02
ATC
pantoprazole; systemic
1.5
22.0
1538
12864
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
18.6
21.7
33
18
137
Kela drug reimbursment
Uraemia requiring dialysis
7.9
21.5
49
63
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.9
21.5
367
2112
H81
ICPC
Excessive ear wax
1.7
21.4
522
3366
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
8.7
21.3
46
54
M79.6
ICD-10 Finland
Pain in limb
1.6
21.3
817
5933
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
21.3
510
3271
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
21.0
670
4647
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
20.9
214
1000
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
4.4
20.9
77
180
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
7.4
20.7
49
67
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
20.6
552
3649
Z2446
NOMESCO Finland
Social worker
2.4
20.3
174
746
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
7.4
20.2
48
66
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
20.1
180
786
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.9
20.1
56
96
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
20.0
943
7161
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.1
20.0
114
382
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
14.5
19.9
33
23
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
19.8
992
7633
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
21.8
19.5
28
13
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
19.5
943
7191
B01AB10
ATC
tinzaparin; parenteral
2.2
19.4
199
933
L03
ICPC
Low back symptom/complaint
1.7
19.2
520
3440
C08CA01
ATC
amlodipine; oral
1.5
19.2
1073
8432
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.0
19.0
61
124
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
18.9
388
2366
C03CA01
ATC
furosemide; systemic
1.5
18.9
1069
8414
R60.0
ICD-10 Finland
Localized oedema
1.8
18.7
346
2040
J01MA02
ATC
ciprofloxacin; systemic
1.5
18.2
996
7766
WXQ99
NOMESCO Finland
Other light therapy
15.4
17.9
29
19
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
17.8
617
4336
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
12.0
17.8
32
27
N18.0
ICD-10 Finland
End-stage renal disease
4.6
17.6
61
135
ZXD05
NOMESCO Finland
Urgent procedure
1.5
17.5
744
5479
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
15.7
17.5
28
18
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
2.9
17.4
107
379
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
17.3
111
404
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
4.5
17.3
61
138
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.6
17.2
562
3889
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
17.2
623
4420
J05AB01
ATC
aciclovir; systemic
1.7
17.1
445
2904
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
17.0
716
5254
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.7
17.0
122
475
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.4
17.0
149
645
KMAK
NOMESCO Finland
NA
1.5
17.0
888
6829
D02AE01
ATC
carbamide; topical
2.3
16.9
167
765
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
16.9
241
1292
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.6
16.9
600
4233
E000001
ATC
NA
1.6
16.9
446
2921
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
7.9
16.8
38
49
ZXC10
NOMESCO Finland
Use of laser
3.8
16.7
70
186
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
5.8
16.6
47
83
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
16.6
988
7787
ZXD20
NOMESCO Finland
Day surgery
1.8
16.5
306
1802
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
9.1
16.4
34
38
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
5.8
16.3
46
81
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
5.2
16.2
50
98
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.5
16.2
47
86
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
5.4
16.0
48
91
XKD00
NOMESCO Finland
Uroflowmetry
1.6
15.9
485
3291
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
15.9
160
741
C44
ICD-10 Finland
Other malignant neoplasms of skin
8.8
15.7
33
38
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
13.0
15.6
27
21
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
15.6
1152
9427
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.3
15.6
151
689
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
15.5
163
774
B05DA
ATC
Isotonic solutions
7.4
15.4
36
49
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
15.4
438
2916
R4120
NOMESCO Finland
Occupational therapy
2.2
15.3
152
701
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
15.3
225
1222
D02AX
ATC
Other emollients and protectives
3.1
15.3
87
292
Z01.2
ICD-10 Finland
Dental examination
1.5
15.2
683
5061
L85.80
ICD-10 Finland
Hudhorn
7.5
15.2
35
47
CBB30
NOMESCO Finland
Excision of lesion of eyelid
2.8
15.0
97
355
D03.5
ICD-10 Finland
Melanoma in situ of trunk
9.5
14.9
30
32
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
31.9
14.8
19
6
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.9
14.8
91
323
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
14.7
929
7352
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
14.6
764
5827
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
14.6
250
1431
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.8
14.5
48
102
R23.4
ICD-10 Finland
Changes in skin texture
5.0
14.4
46
94
L57
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation
8.9
14.4
30
34
M04AA01
ATC
allopurinol; systemic
1.6
14.2
429
2892
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
14.2
669
4992
SPAT1325
SPAT
Vaccination
1.4
14.2
960
7683
K03.64
ICD-10 Finland
Dental calculus supragingival
1.6
14.1
425
2865
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
14.1
1004
8108
J05AB11
ATC
valaciclovir; oral
1.7
13.9
287
1745
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
23.9
13.8
19
8
Z02.4
ICD-10 Finland
Examination for driving licence
1.5
13.8
694
5242
S97
ICPC
Chronic ulcer skin
2.0
13.8
181
942
B03XA01
ATC
erythropoietin; parenteral
4.6
13.7
47
104
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
13.7
314
1965
B03XA02
ATC
darbepoetin alfa; parenteral
3.2
13.7
72
231
A28
ICPC
Limited function/disability NOS
1.5
13.6
542
3896
TK800
NOMESCO Finland
Hemodialysis
3.2
13.6
72
232
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
5.9
13.6
37
63
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
5.4
13.6
40
75
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.3
13.6
132
603
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
5.3
13.4
40
76
C07AB07
ATC
bisoprolol; oral
1.4
13.4
1349
11531
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
3.6
13.3
60
171
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
8.6
13.2
28
33
U02
ICPC
Urinary frequency/urgency
1.6
13.2
328
2102
ZXA10
NOMESCO Finland
Bilateral
1.5
13.2
511
3647
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
40.3
13.1
16
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
13.0
201
1111
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.9
13.0
80
284
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
16.8
13.0
20
12
VALMI
NOMESCO Finland
NA
1.6
12.9
397
2686
C44.92
ICD-10 Finland
Unspecified localization of spinocellular carcinoma of the skin
19.1
12.9
19
10
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
12.9
646
4865
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
12.9
909
7292
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.7
12.7
54
147
L13
ICPC
Hip symptom/complaint
1.6
12.7
414
2839
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.8
12.7
35
61
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
12.6
619
4636
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
12.3
12.6
22
18
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
12.5
647
4897
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
12.5
353
2338
R53
ICD-10 Finland
Malaise and fatigue
1.5
12.5
528
3837
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
20.1
12.4
18
9
B05DB
ATC
Hypertonic solutions
7.6
12.4
28
37
ZX120
NOMESCO Finland
Intravenous
1.8
12.4
228
1338
M54.5
ICD-10 Finland
Low back pain
1.4
12.3
623
4692
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
12.3
370
2487
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
11.7
12.3
22
19
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
12.3
559
4123
Z01.7
ICD-10 Finland
Laboratory examination
1.7
12.1
244
1468
M25.5
ICD-10 Finland
Pain in joint
1.5
12.1
503
3638
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.5
12.1
396
2718
C08CA02
ATC
felodipine; oral
1.6
12.1
313
2027
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
6.6
12.0
30
46
R31
ICD-10 Finland
Unspecified haematuria
1.6
12.0
303
1950
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
3.8
11.9
50
135
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
6.8
11.9
29
43
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
11.9
360
2424
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.3
11.9
105
460
S16
ICPC
Bruise/contusion
2.4
11.9
99
421
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
11.8
212
1233
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
10.6
11.7
22
21
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.6
11.7
40
89
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
11.7
802
6372
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
9.7
11.7
23
24
205
Kela drug reimbursment
Chronic hypertension
1.4
11.7
913
7417
-54
ICPC
Repair/fix-suture/cast/prosth device
2.7
11.7
81
311
Z49.2
ICD-10 Finland
Other dialysis
6.3
11.7
30
48
L28
ICPC
Limited function/disability (L)
1.5
11.6
484
3497
D23.4
ICD-10 Finland
Benign neoplasm: Skin of scalp and neck
4.9
11.6
37
77
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
11.1
11.5
21
19
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.3
11.5
108
487
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
10.1
11.5
22
22
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
11.5
96
408
-44
ICPC
Preventive immunization/medic
1.7
11.4
259
1615
F16
ICPC
Eyelid symptom/complaint
2.2
11.4
117
547
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
11.4
94
398
XW000
NOMESCO Finland
Bone marrow biopsy
2.2
11.4
120
570
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.2
11.4
58
183
J01FA10
ATC
azithromycin; systemic
1.4
11.4
937
7669
L08
ICPC
Shoulder symptom/complaint
1.5
11.4
402
2804
UKC02
NOMESCO Finland
Cystoscopy
1.5
11.3
487
3540
S79
ICPC
Neoplasm skin benign/unspecified
3.0
11.3
62
207
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
11.2
191
1090
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
11.2
200
1160
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
11.2
263
1657
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.5
11.2
472
3420
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
11.2
132
660
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
11.1
116
550
C09CA01
ATC
losartan; oral
1.4
11.1
618
4722
R06AE07
ATC
cetirizine; oral
1.4
11.1
769
6107
H02AB07
ATC
prednisone; oral
1.6
11.1
350
2374
D07AA02
ATC
hydrocortisone; topical
1.7
11.1
265
1675
S04
ICPC
Lump/swelling localized
1.8
11.1
194
1119
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
11.1
99
435
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
11.2
11.0
20
18
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
11.0
169
931
ZXC12
NOMESCO Finland
Pulse colorlaser
13.9
11.0
18
13
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
6.9
10.8
26
38
WX402
NOMESCO Finland
General anaesthesia
1.6
10.8
277
1786
M01AX05
ATC
glucosamine; oral
1.4
10.8
587
4466
J01AA02
ATC
doxycycline; systemic
1.4
10.7
1688
15216
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
10.7
128
642
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.0
10.7
59
198
R74
ICPC
Upper respiratory infection acute
1.5
10.7
345
2354
ZY010
NOMESCO Finland
Hospital outpatient
2.8
10.7
68
250
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
12.9
10.6
18
14
-1
NOMESCO Finland
NA
1.4
10.6
523
3901
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
10.6
690
5412
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
10.6
445
3217
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
10.5
490
3615
R06.0
ICD-10 Finland
Dyspnoea
1.4
10.5
633
4901
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
10.5
702
5535
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
10.5
485
3576
A08
ICPC
Swelling
2.0
10.5
129
657
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
10.5
394
2785
WW200
NOMESCO Finland
Immunization
2.9
10.4
61
212
D01AE16
ATC
amorolfine; topical
1.6
10.4
281
1834
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
10.3
116
567
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
10.2
139
735
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
3.4
10.2
48
144
QAA25
SPAT
NA
13.2
10.1
17
13
G04CA02
ATC
tamsulosin; oral
1.4
10.1
663
5198
R35
ICD-10 Finland
Polyuria
1.8
10.1
175
1007
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
10.1
451
3298
SPAT1211
SPAT
Application of soft bandage
1.6
10.1
239
1509
L12
ICPC
Hand/finger symptom/complaint
1.6
10.1
273
1788
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
10.0
200
1203
5AB14
NOMESCO Finland
NA
40.2
10.0
12
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.9
9.9
147
804
R05
ICD-10 Finland
Cough
1.5
9.9
407
2930
7151
FHL
Kidney transplantation
16.8
9.9
15
9
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
9.9
165
937
A02BC05
ATC
esomeprazole; systemic
1.3
9.9
841
6879
EAA30
NOMESCO Finland
Partial excision of lower lip
12.2
9.8
17
14
C44.9
ICD-10 Finland
Malignant neoplasm: Malignant neoplasm of skin, unspecified
26.1
9.8
13
5
EB1AA
SPAT
NA
2.3
9.7
86
379
D01BA02
ATC
terbinafine; oral; topical
1.4
9.7
508
3826
C08CA13
ATC
lercanidipine; oral
1.5
9.7
375
2663
H13
ICPC
Plugged feeling ear
1.4
9.7
471
3503
R21
ICPC
Throat symptom/complaint
1.6
9.6
247
1590
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
4.1
9.6
36
89
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
9.6
191
1148
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
9.6
484
3621
R50.9
ICD-10 Finland
Fever, unspecified
1.5
9.6
313
2138
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
9.6
124
641
J01MA12
ATC
levofloxacin; systemic
1.4
9.6
462
3425
J01FF01
ATC
clindamycin; systemic
1.4
9.6
540
4121
E000002
ATC
NA
1.7
9.6
204
1251
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
11.4
9.6
17
15
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.6
9.5
223
1404
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
9.5
384
2748
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.7
9.5
221
1387
C44.99
ICD-10 Finland
Unspecified localization of malignant tumor in skin other or unspecified histology
9.1
9.5
19
21
A02BC01
ATC
omeprazole; systemic
1.4
9.5
683
5429
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
7.2
9.5
22
31
GDG10
NOMESCO Finland
Bilateral transplantation of lung
100.4
9.4
10
*
QXA05
NOMESCO Finland
Skin division, unspecified location
7.6
9.4
21
28
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
9.4
240
1544
S99
ICPC
Skin disease other
2.7
9.4
60
222
M02AA07
ATC
piroxicam; topical
1.3
9.3
876
7251
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
9.3
224
1420
M19.8
ICD-10 Finland
Other specified arthrosis
2.3
9.3
87
393
SPAT1336
SPAT
Request for examination
2.1
9.2
102
497
Z73.6
ICD-10 Finland
Limitation of activities due to disability
4.0
9.2
35
88
S15
ICPC
Foreign body in skin
1.9
9.2
143
793
H26.4
ICD-10 Finland
After-cataract
1.5
9.2
327
2279
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.7
9.2
177
1053
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
4.7
9.2
30
65
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.8
9.2
58
212
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.1
9.2
104
513
S76
ICPC
Skin infection other
1.9
9.2
125
662
R05
ICPC
Cough
1.4
9.1
433
3198
M10.9
ICD-10 Finland
Gout, unspecified
1.7
9.1
193
1182
N03AX16
ATC
pregabalin; oral
1.4
9.1
501
3802
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
3.9
9.1
36
94
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
9.1
788
6441
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
9.0
503
3831
R23
ICD-10 Finland
Other skin changes
4.3
9.0
32
76
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.0
9.0
111
567
D06BX01
ATC
metronidazole; topical
1.7
8.9
199
1234
Z94.2
ICD-10 Finland
Lung transplant status
24.1
8.9
12
5
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
8.9
87
401
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
8.9
279
1892
D19
ICPC
Teeth/gum symptom/complaint
1.5
8.8
378
2735
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
8.8
476
3599
CBA10
NOMESCO Finland
Biopsy of eyelid
3.6
8.8
38
107
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.5
8.8
291
1996
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
8.7
416
3071
V03AE01
ATC
polystyrene sulfonate; oral
3.1
8.7
46
151
XF404
NOMESCO Finland
Ambulatory ECG
1.6
8.7
248
1639
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.5
8.7
328
2314
3AC01
NOMESCO Finland
NA
3.8
8.7
35
93
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
7.6
8.6
19
25
207
Kela drug reimbursment
Chronic arrhythmias
1.4
8.6
478
3632
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
5.8
8.6
23
40
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
8.2
8.6
18
22
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.3
8.5
77
343
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
10.1
8.5
16
16
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
2.5
8.5
63
255
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
8.5
1260
11064
U13
ICPC
Bladder symptom/complaint other
2.2
8.5
82
377
B35.1
ICD-10 Finland
Tinea unguium
1.9
8.5
118
632
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
8.5
63
256
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.4
8.5
385
2822
A11
ICPC
Chest pain NOS
1.6
8.4
196
1231
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
3.1
8.4
44
144
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
90.3
8.4
9
*
A12BA01
ATC
potassium chloride; oral
1.7
8.3
189
1181
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
8.3
8
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
8.3
301
2102
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
8.3
35
97
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
8.3
396
2923
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
8.5
8.3
17
20
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
8.3
118
636
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
10.8
8.3
15
14
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
8.3
243
1621
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
7.1
8.2
19
27
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
4.0
8.2
31
78
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.5
8.2
334
2392
S02.51
ICD-10 Finland
Fracture of tooth, open
1.7
8.2
151
889
K78
ICPC
Atrial fibrillation/flutter
1.5
8.2
274
1883
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
8.2
394
2916
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.1
8.1
85
406
WVA20
NOMESCO Finland
Medicine administration
2.7
8.1
54
206
C09CA06
ATC
candesartan; oral
1.4
8.1
452
3432
40399
ICD-8 Finland
Hypertensive renal disease
8.1
8.1
17
21
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
8.1
128
718
H02AB04
ATC
methylprednisolone; systemic
1.5
8.0
314
2228
M01AH05
ATC
etoricoxib; oral
1.3
8.0
993
8494
Z94.4
ICD-10 Finland
Liver transplant status
10.0
8.0
15
15
L14
ICPC
Leg/thigh symptom/complaint
1.7
8.0
179
1114
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
6.3
8.0
20
32
M15
ICD-10 Finland
Polyarthrosis
1.8
8.0
138
795
N17
ICPC
Vertigo/dizziness
1.5
8.0
294
2061
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
8.0
228
1509
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.8
8.0
49
179
V03AE02
ATC
sevelamer; oral
5.5
8.0
22
40
R42
ICD-10 Finland
Dizziness and giddiness
1.3
8.0
567
4485
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
8.0
277
1920
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
8.0
147
867
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
7.9
216
1415
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
13.1
7.9
13
10
C44.90
ICD-10 Finland
Unspecified localization of malignant tumor of the skin without histology
13.1
7.9
13
10
D11
ICPC
Diarrhoea
1.7
7.9
171
1054
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.6
7.9
198
1269
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
7.9
233
1559
-59
ICPC
Other therap proced/minor surg NEC
2.2
7.8
76
353
D07AC13
ATC
mometasone; topical
1.3
7.8
553
4366
R4130
NOMESCO Finland
Speech therapy
2.5
7.8
58
235
S19
ICPC
Skin injury other
2.0
7.8
100
519
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
7.8
384
2854
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
7.8
122
682
R04.0
ICD-10 Finland
Epistaxis
1.6
7.8
203
1314
L15
ICPC
Knee symptom/complaint
1.4
7.7
424
3206
A97
ICPC
No disease
1.4
7.7
325
2342
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
15.1
7.7
12
8
H02AB06
ATC
prednisolone; systemic
1.3
7.7
1021
8794
P01AB01
ATC
metronidazole; oral, rectal
1.3
7.7
714
5867
JN4BD
NOMESCO Finland
Extensive body CT
1.5
7.7
281
1968
J02AC01
ATC
fluconazole; systemic
1.3
7.7
604
4842
R01AD09
ATC
mometasone; nasal
1.3
7.7
692
5660
1XC02
NOMESCO Finland
NA
4.6
7.7
25
55
PJA12
NOMESCO Finland
Sentinel node biopsy
1.7
7.6
154
933
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
7.6
90
453
G04BD12
ATC
mirabegron; oral
1.5
7.6
270
1879
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
18.4
7.6
11
6
D03.30
ICD-10 Finland
Melanoma in situ on the lip
18.4
7.6
11
6
E000007
ATC
NA
1.9
7.6
101
534
V03AE03
ATC
lanthanum carbonate; oral
8.0
7.6
16
20
N02AX02
ATC
tramadol; systemic, rectal
1.3
7.6
932
7949
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
25.1
7.6
10
*
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
25.1
7.6
10
*
A99
ICPC
Disease/condition unspecnature/site
1.6
7.6
184
1171
S56
ICPC
Skin, Dressing/pressure/compress/tamponade
3.6
7.5
32
90
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
10.0
7.5
14
14
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
7.4
241
1642
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
80.3
7.4
8
*
XX4BW
NOMESCO Finland
NA
80.3
7.4
8
*
J01FA06
ATC
roxithromycin; oral
1.3
7.4
811
6812
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.4
7.3
59
251
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
2.4
7.3
56
232
J01CF05
ATC
flucloxacillin; systemic
2.1
7.3
79
383
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.6
7.3
191
1237
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.4
7.3
382
2866
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.3
291
2077
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
7.2
768
6412
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
7.2
109
602
C02AC05
ATC
moxonidine; oral
1.8
7.2
124
717
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.8
7.2
127
738
212
Kela drug reimbursment
Gout
2.2
7.2
71
334
R83
ICPC
Respiratory infection other
1.5
7.1
219
1476
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
30.1
7.1
9
*
K07
ICPC
Swollen ankles/oedema
1.7
7.1
136
810
A06AC51
ATC
ispaghula, combinations; systemic
1.8
7.1
118
671
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
7.1
210
1401
A03
ICPC
Fever
1.6
7.1
204
1351
WX290
NOMESCO Finland
Other blockade of nerve
1.3
7.1
530
4207
L84
ICD-10 Finland
Corns and callosities
2.0
7.1
84
424
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
5.6
7.1
19
34
M01AB05
ATC
diclofenac; systemic, rectal
1.3
7.0
1242
11034
UJF32
NOMESCO Finland
Coloscopy
1.3
7.0
613
4980
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.6
7.0
158
986
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
7.0
412
3152
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
7.0
7.0
16
23
EAA10
NOMESCO Finland
Excision of lesion of lip
3.0
7.0
37
124
WX892
NOMESCO Finland
Monitored bed care
1.6
6.9
184
1199
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.0
6.9
81
408
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.8
6.9
120
694
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
6.3
6.9
17
27
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
6.3
6.9
17
27
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.7
6.9
137
826
GD1LA
NOMESCO Finland
GD
2.6
6.9
48
187
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.6
6.9
180
1169
B01AF02
ATC
apixaban; oral
1.4
6.9
303
2204
S51.0
ICD-10 Finland
Open wound of elbow
3.0
6.9
36
120
R4190
NOMESCO Finland
Nutritional therapy
2.4
6.8
55
234
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
6.8
346
2580
J20
ICD-10 Finland
Acute bronchitis
1.6
6.8
184
1201
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
6.7
6.8
16
24
R02
ICPC
Shortness of breath/dyspnoea
1.4
6.8
278
1993
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.3
6.8
57
246
K05.30
ICD-10 Finland
Periodontitis complex
1.5
6.8
232
1602
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.6
6.8
165
1051
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.9
6.8
39
136
ZX197
NOMESCO Finland
NA
40.1
6.8
8
*
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
16.7
6.7
10
6
WZC30
NOMESCO Finland
Teaching
1.5
6.7
258
1823
H02.1
ICD-10 Finland
Ectropion of eyelid
2.5
6.7
48
192
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.5
6.7
237
1648
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.7
367
2773
B01AB04
ATC
dalteparin; parenteral
1.7
6.7
128
763
D09.9
ICD-10 Finland
Carcinoma in situ, unspecified
22.6
6.7
9
*
C10AA05
ATC
atorvastatin; oral
1.3
6.7
963
8339
ZX108
NOMESCO Finland
Inhalation
3.9
6.7
25
64
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
6.7
291
2112
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
6.7
626
5135
WX110
SPAT
NA
2.1
6.6
67
317
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
6.6
219
1500
XF402
NOMESCO Finland
ECG with work load test
1.4
6.6
276
1986
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.8
6.6
99
548
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
7.8
6.6
14
18
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
5.5
6.6
18
33
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
6.6
382
2913
L16
ICPC
Ankle symptom/complaint
1.6
6.6
183
1208
U71
ICPC
Cystitis/urinary infection other
1.7
6.5
132
800
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
6.5
292
2126
K80
ICD-10 Finland
Cholelithiasis
3.2
6.5
32
102
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
6.5
197
1325
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
4.0
6.5
24
61
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
6.5
136
833
RS222
NOMESCO Finland
NA
2.8
6.5
38
136
N30
ICD-10 Finland
Cystitis
1.6
6.5
151
955
H26.3
ICD-10 Finland
Drug-induced cataract
5.3
6.5
18
34
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
6.4
107
613
QA6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in cheeks or nose
70.0
6.4
7
*
ZX100
NOMESCO Finland
Oral
2.8
6.4
38
137
U01
ICPC
Dysuria/painful urination
1.6
6.4
155
990
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
4.1
6.4
23
57
E000006
ATC
NA
1.6
6.4
150
951
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.0
6.4
72
359
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
6.3
135
830
H01.0
ICD-10 Finland
Blepharitis
1.9
6.3
85
453
L01XX05
ATC
hydroxycarbamide; oral
2.6
6.3
42
162
EBA00
NOMESCO Finland
Extraction of tooth
1.3
6.3
563
4582
Z94.1
ICD-10 Finland
Heart transplant status
9.3
6.3
12
13
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
2.6
6.3
43
170
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.1
6.3
64
304
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
1.6
6.3
158
1017
WW500
NOMESCO Finland
Blood transfusion
1.8
6.2
96
537
SPAT1312
SPAT
General health counselling
1.3
6.2
623
5145
M54
ICD-10 Finland
Dorsalgia
1.5
6.2
185
1238
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.6
6.2
44
174
D82
ICPC
Teeth/gum disease
1.3
6.2
473
3760
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
6.2
182
1215
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.2
6.2
59
273
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.2
627
5185
J01DA06
ATC
[U] cefuroxime; systemic
1.4
6.2
269
1952
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.2
247
1762
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
6.2
180
1203
L71.9
ICD-10 Finland
Rosacea, unspecified
2.6
6.2
41
159
S80
ICPC
Solar keratosis/sunburn
5.3
6.1
17
32
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
6.1
296
2190
D07XC01
ATC
betamethasone, combinations; topical
1.5
6.1
235
1664
H02AB09
ATC
hydrocortisone; systemic
2.5
6.1
44
178
C09AA02
ATC
enalapril; systemic
1.3
6.1
549
4471
A10
ICPC
Bleeding/haemorrhage NOS
3.2
6.1
29
91
T92
ICPC
Gout
2.2
6.1
59
277
QDA10
NOMESCO Finland
Incision of skin of lower limb
4.0
6.1
22
55
K05.1
ICD-10 Finland
Chronic gingivitis
1.8
6.1
98
556
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
3.7
6.1
24
65
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
2.9
6.1
35
123
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
3.3
6.1
28
86
L21.0
ICD-10 Finland
Seborrhoea capitis
3.3
6.1
28
86
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
4.9
6.0
18
37
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.2
6.0
55
249
L01BB01
ATC
NA
6.7
6.0
14
21
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
6.7
6.0
14
21
ZZS00
NOMESCO Finland
Rotation flap
6.7
6.0
14
21
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.9
6.0
84
454
M05BA04
ATC
alendronic acid; oral
1.4
6.0
265
1929

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
1099
2819
5.77
307.65
2.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2196
8449
8.40
307.65
4.4
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
390
1002
4.36
138.19
1.3
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
94
49
19.82
121.09
30.0
26.3
ug/l
93.5
108.0
0.90
85
42
(3021589) Normoblasts [#/volume] in Blood
1534
9245
2.46
116.36
14.5
10.6
e9/l
0.0
0.0
1.11
1255
7460
(3030467) Casts [#/volume] in Urine by Automated count
1249
7211
2.32
99.83
4.9
3.5
e6/l
0.5
0.6
0.98
976
5580
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2460
19234
3.29
98.63
26.0
18.3
ml/min/173m2
65.0
68.5
13.41
2135
15967
(3018095) Leukocytes [#/volume] in Urine
1437
8927
2.25
94.76
5.8
4.1
e6/l
104.0
137.0
0.88
1063
6592
(42870588) Differential panel, method unspecified - Blood
1296
7739
2.26
93.91
7.8
5.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2170
16147
2.53
91.38
31.8
23.1
%
14.2
14.0
3.38
2116
15729
(36304419) Bacteria [Presence] in Urine
1186
6895
2.25
91.00
4.9
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1308
7920
2.22
90.66
5.1
3.6
e6/l
51.3
101.7
1.69
1031
6209
(3022096) Basophils/100 leukocytes in Blood
1533
9912
2.21
89.83
8.6
5.5
%
0.6
0.6
0.79
1427
9111
(3006315) Basophils [#/volume] in Blood
1627
10802
2.21
88.78
8.0
5.2
e9/l
0.0
0.0
0.61
1369
9102
(3001604) Monocytes [#/volume] in Blood
1620
10743
2.20
88.58
8.0
5.2
e9/l
0.6
0.6
0.07
1360
9021
(3019069) Monocytes/100 leukocytes in Blood
1559
10215
2.19
87.46
8.9
5.8
%
9.2
9.0
0.79
1448
9397
(3006504) Eosinophils/100 leukocytes in Blood
1551
10174
2.18
86.35
8.7
5.5
%
2.6
2.8
2.61
1441
9338
(3019198) Lymphocytes [#/volume] in Blood
1634
10987
2.17
84.73
8.0
5.3
e9/l
2.1
1.8
1.77
1387
9411
(3013115) Eosinophils [#/volume] in Blood
1650
11149
2.17
84.32
8.3
5.4
e9/l
0.2
0.2
4.95
1416
9516
(3002030) Lymphocytes/100 leukocytes in Blood
1566
10380
2.15
83.98
8.7
5.8
%
25.3
25.2
0.10
1457
9477
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
1446
9319
2.14
83.16
5.1
3.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1540
10201
2.13
81.98
8.3
5.5
%
59.6
59.4
0.15
1433
9377
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2553
21024
3.42
80.83
25.7
18.9
mg/l
27.2
28.1
0.62
2175
17620
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2604
21769
3.79
78.95
14.8
11.4
u/l
22.7
23.4
1.41
2473
20644
(3019550) Sodium [Moles/volume] in Serum or Plasma
2632
22160
4.11
78.76
30.2
22.9
mmol/l
139.3
139.5
1.63
2573
21510
(3007461) Platelets [#/volume] in Blood
2647
22371
4.33
78.73
37.0
27.8
e9/l
230.9
238.2
5.37
2551
21598
(3035941) MCH [Entitic mass]
2647
22373
4.33
78.68
36.9
27.7
pg
30.5
30.4
3.10
2594
21849
(3024731) MCV [Entitic volume]
2647
22373
4.33
78.68
36.9
27.7
fl
92.7
91.9
11.05
2593
21848
(3026361) Erythrocytes [#/volume] in Blood
2647
22374
4.33
78.65
37.0
27.8
e12/l
4.3
4.3
7.64
2534
21499
(3010813) Leukocytes [#/volume] in Blood
2647
22378
4.33
78.54
37.1
27.8
e9/l
7.1
7.0
0.56
2542
21496
(3000963) Hemoglobin [Mass/volume] in Blood
2647
22378
4.33
78.54
37.3
28.0
g/l
128.5
130.3
7.68
2594
21863
(3023103) Potassium [Moles/volume] in Serum or Plasma
2633
22183
4.12
78.51
30.8
23.1
mmol/l
4.0
4.0
0.72
2571
21498
(3013650) Neutrophils [#/volume] in Blood by Automated count
1784
12719
2.11
75.39
11.1
8.1
e9/l
4.3
4.4
1.02
1532
10954
(3033658) Prothrombin time (PT) actual/Normal
1006
5857
2.12
73.08
5.2
4.0
%
79.9
82.4
2.08
993
5699
(3026250) Tacrolimus [Mass/volume] in Blood
62
39
16.23
72.80
31.3
28.0
ug/l
5.9
6.6
1.40
52
34
(3009542) Hematocrit [Volume Fraction] of Blood
2239
17562
2.37
72.73
28.3
20.9
%
38.2
37.2
5.16
1448
9920
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
790
4205
2.22
71.98
4.1
3.2
e6/l
1.9
2.4
0.93
447
2392
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2467
20272
2.82
71.68
5.8
5.5
mmol/l
2.4
2.5
8.68
2180
17901
(3026782) Osmolality of Urine
935
5399
2.10
68.52
4.2
3.0
mosm/kgh2o
523.6
541.8
2.09
798
4583
(3018418) pH of Serum or Plasma
1230
7896
1.99
66.75
5.9
3.8
ph
7.4
7.4
0.36
255
1445
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2353
19108
2.45
66.37
5.3
4.9
mu/l
2.1
2.1
0.03
2087
16795
(40758558) Short blood count panel - Blood
944
5537
2.06
65.79
8.3
6.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
960
5670
2.05
65.61
3.8
2.7
e6/l
4.0
5.2
3.19
836
4993
(3044889) 12 lead EKG panel
2017
15482
2.08
64.30
5.3
4.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2221
17699
2.23
63.93
9.9
7.4
u/l
81.9
82.4
0.19
2052
16433
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2388
19620
2.47
63.84
7.0
6.9
mmol/mol
40.5
41.5
5.31
2146
17548
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1351
9066
1.95
63.37
3.6
2.8
ug/l
146.4
154.4
0.62
1200
8072
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
800
4492
2.09
62.10
3.9
3.0
e6/l
0.8
1.3
4.30
455
2657
(3037467) Urinalysis macro (dipstick) panel - Urine
2064
16087
2.08
61.53
6.4
5.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2070
16171
2.07
61.03
6.8
5.6
e6/l
2640.6
3269.7
0.11
22
300
(40761511) CBC panel - Blood by Automated count
2497
21079
2.70
60.53
22.4
18.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1590
11405
1.91
59.56
5.9
4.4
g/l
34.1
34.2
0.31
1447
10429
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2432
20325
2.49
59.41
5.6
5.3
mmol/l
6.1
6.1
1.91
2107
17756
(3004789) Transferrin [Mass/volume] in Serum or Plasma
717
4013
2.06
55.16
3.2
2.4
g/l
2.2
2.3
2.22
645
3665
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
688
3797
2.08
54.96
3.3
2.5
%
20.4
21.1
0.85
602
3158
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2352
19575
2.26
54.60
5.0
4.8
mmol/l
4.2
4.4
6.93
2070
17346
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2326
19333
2.20
53.19
4.9
4.7
mmol/l
1.4
1.5
0.44
2027
16982
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1628
12013
1.85
53.17
7.5
5.7
mmol/l
1.2
1.2
0.60
1472
10707
(4035726)
437
2035
2.36
53.12
1.5
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1755
13274
1.86
52.73
8.6
6.4
mmol/l
1.2
1.2
0.74
1435
11094
(3013707) Erythrocyte sedimentation rate by Westergren method
2042
16336
1.92
49.98
5.2
4.3
mm/h
16.2
15.8
0.44
1833
14749
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
875
5410
1.90
49.53
3.1
3.1
mmol/l
2.5
2.5
0.02
751
4678
(3015377) Calcium [Moles/volume] in Serum or Plasma
1277
8888
1.80
49.18
3.6
3.2
mmol/l
2.3
2.4
0.60
1090
7438
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2255
18704
2.05
49.06
4.4
4.2
mmol/l
1.2
1.2
1.52
1945
16224
(3022948) Iron [Moles/volume] in Serum or Plasma
740
4347
1.95
48.75
3.3
2.4
umol/l
11.2
11.6
0.86
677
3958
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
175
524
3.50
48.62
5.1
2.5
mg/l
2.0
1.8
1.89
160
453
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1543
11419
1.78
47.66
2.4
2.2
pmol/l
92.6
92.9
0.07
795
5806
(3026493) Urate [Moles/volume] in Serum or Plasma
952
6144
1.83
46.43
3.9
2.9
umol/l
5110.2
7681.8
0.82
791
5077
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
133
346
3.99
45.34
9.3
4.1
iu/ml
1012.3
5395.8
0.44
26
47
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1951
15695
1.80
43.04
4.1
4.0
pmol/l
15.1
15.3
1.09
1698
13692
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1063
7253
1.75
41.89
2.7
2.3
mg/l
3.2
3.2
0.04
897
6102
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
584
3311
1.97
41.88
4.6
3.6
u/l
269.5
248.0
1.41
555
3078
(3023368) Bacteria identified in Blood by Culture
1163
8183
1.72
40.73
5.4
4.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1505
11366
1.70
40.44
14.8
11.7
inr
1.4
1.4
0.13
458
3014
(3003458) Phosphate [Moles/volume] in Serum or Plasma
594
3464
1.91
38.83
9.1
4.7
mmol/l
1.0
1.0
0.32
548
3148
(3021960) Folate [Moles/volume] in Serum or Plasma
1015
7009
1.70
37.18
1.7
1.6
nmol/l
20.7
20.1
0.61
875
5872
(3013826) Glucose [Moles/volume] in Serum or Plasma
1805
14504
1.69
36.67
5.4
4.7
mmol/l
6.8
6.9
2.18
1718
13657
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1285
9474
1.66
36.44
2.6
2.2
nmol/l
83.4
80.5
3.15
1104
8099
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1236
9028
1.66
36.31
2.3
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
490
2736
1.96
36.23
4.4
3.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
608
3644
1.85
36.20
2.8
2.3
%
1.8
1.8
0.18
532
3157
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1610
12601
1.65
35.82
6.7
5.8
umol/l
13.1
12.3
1.08
1516
11875
(3020779) Urea [Moles/volume] in Serum or Plasma
449
2443
2.00
35.74
11.0
5.6
mmol/l
12.4
11.6
1.35
430
2289
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
406
2131
2.06
35.71
2.8
2.3
u/l
30.9
37.2
2.08
350
1774
(3000991) Gas panel - Venous blood
425
2271
2.03
35.58
7.2
6.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
495
2813
1.92
34.61
2.0
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
442
2418
1.98
34.55
1.6
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1079
7691
1.66
34.32
3.2
2.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
279
1295
2.28
33.44
4.7
3.4
mmol/l
23.7
24.1
1.09
258
1153
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
450
2542
1.92
31.82
3.0
2.5
umol/l
10.2
10.0
0.10
402
2206
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1260
9529
1.59
30.27
3.5
3.3
ng/l
2756.0
1963.0
2.60
1108
8307
(3012095) Magnesium [Moles/volume] in Serum or Plasma
638
4081
1.73
29.74
3.5
2.7
mmol/l
0.8
0.8
0.49
576
3733
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
98
279
3.60
29.36
4.3
2.2
u/ml
185.7
1181.8
—
7
19
(3042936) Bacteria identified in Isolate by Culture
567
3537
1.76
28.78
2.2
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
737
4945
1.67
28.58
2.1
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
392
2216
1.89
27.38
5.2
3.3
ng/l
124.8
96.2
3.36
334
1826
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
839
5867
1.61
27.37
3.0
2.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
293
1499
2.07
27.29
1.8
1.7
g/l
1.4
1.5
1.89
264
1267
(3018677) aPTT in Platelet poor plasma by Coagulation assay
636
4150
1.69
27.25
2.2
1.9
s
30.8
30.0
2.27
619
3993
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1462
11669
1.53
26.14
3.2
3.1
u/l
56.5
57.6
0.13
1308
10382
(3002179) Metamyelocytes/100 leukocytes in Blood
321
1724
1.97
26.06
4.8
3.8
%
0.4
0.6
0.95
89
412
(46235355) HIV 1 and 2 tests - Meaningful Use set
304
1609
2.00
25.72
1.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
540
3419
1.72
25.69
1.9
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
777
5403
1.61
25.64
4.5
4.3
ng/l
424.8
502.5
0.14
713
4814
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
542
3450
1.71
25.24
1.9
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
427
2540
1.80
25.21
2.4
2.5
g/l
65.3
65.9
0.77
390
2252
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
755
5235
1.61
25.13
1.6
1.6
mmol/l
1.3
1.3
0.08
588
4291
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1128
8566
1.53
25.10
6.0
5.8
ug/l
2.8
5.1
2.75
965
7490
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
13
16.27
24.57
6.2
5.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
452
2766
1.76
24.15
3.1
2.4
e9/l
66.9
67.7
0.17
309
2122
(3003338) MCHC [Mass/volume]
1889
16101
1.53
23.58
34.6
25.7
g/l
329.2
330.2
5.48
1870
15889
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
344
1955
1.87
23.45
1.8
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
697
4812
1.60
23.35
3.6
3.4
ug/l
0.8
0.9
1.09
535
3540
(40761536) Microorganisms panel - Urine sediment
332
1884
1.86
22.71
6.3
4.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
188
869
2.25
22.61
2.1
2.3
g/l
0.0
0.1
1.89
171
780
(3021601) Nitrite [Presence] in Urine by Test strip
1388
11162
1.48
22.58
7.1
5.9
estimate
0.0
0.0
0.00
335
2000
(3014111) Lactate [Moles/volume] in Serum or Plasma
405
2447
1.77
22.51
5.2
5.4
mmol/l
1.4
1.4
0.34
386
2339
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
111
402
2.83
22.34
3.8
3.6
%
59.1
59.9
0.19
111
402
(3026008) Bacteria identified in Urine by Culture
1176
9164
1.49
22.31
4.4
3.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
153
651
2.43
22.26
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
153
651
2.43
22.26
1.4
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
364
2143
1.80
22.07
2.2
2.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
378
2251
1.79
22.05
5.9
3.5
mmol/l
1.2
1.2
0.32
318
1929
(3035350) Ketones [Presence] in Urine by Test strip
1386
11180
1.47
21.97
5.1
4.4
estimate
0.0
0.0
0.00
328
2025
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
146
615
2.45
21.71
1.8
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
302
1688
1.88
21.62
5.2
3.9
%
0.2
0.3
0.27
97
451
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
269
1458
1.93
21.12
1.7
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
352
2078
1.79
21.10
1.7
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
173
797
2.25
20.97
3.6
3.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
174
804
2.24
20.94
2.1
2.3
g/l
0.0
0.0
0.00
161
732
(3021440) Promyelocytes/100 leukocytes in Blood
319
1832
1.84
20.94
5.3
3.9
%
0.1
0.1
0.30
109
551
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
176
818
2.23
20.88
2.1
2.3
g/l
0.0
0.0
0.00
161
733
(3009261) Glucose [Presence] in Urine by Test strip
1394
11331
1.46
20.79
5.2
4.5
estimate
0.0
0.0
0.50
328
1998
(3017181) Myelocytes/100 leukocytes in Blood
331
1928
1.81
20.74
5.4
3.8
%
0.8
1.0
0.43
111
595
(3015736) pH of Urine
1132
8846
1.47
20.69
4.5
4.1
—
6.2
—
0
6
(3017143) Hepatitis C virus Ab [Presence] in Serum
261
1418
1.93
20.33
1.8
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
217
1109
2.04
20.14
2.6
2.5
u/ml
0.4
0.3
0.22
123
649
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
202
1006
2.09
20.10
2.3
2.4
g/l
0.8
1.2
1.08
178
836
(3002032) Base excess in Venous blood by calculation
433
2747
1.68
20.02
4.9
3.3
mmol/l
1.5
2.0
1.45
359
2205
(3021447) Carbon dioxide [Partial pressure] in Venous blood
435
2769
1.68
19.85
4.8
3.3
kpa
5.8
5.8
0.24
421
2676
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1317
10670
1.44
19.52
4.9
4.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1025
7924
1.46
19.48
2.3
2.2
u/l
166.2
226.0
2.46
957
7347
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
227
1205
1.96
18.91
2.0
2.3
g/l
7.5
7.6
0.09
182
857
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
264
1480
1.87
18.65
6.2
7.1
mmol/l
24.4
24.4
0.02
250
1350
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
226
1204
1.95
18.63
2.0
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
225
1202
1.95
18.40
2.0
2.3
g/l
3.6
3.8
1.17
175
831
(3007164) IgA [Mass/volume] in Serum or Plasma
485
3232
1.61
18.33
1.8
1.5
g/l
2.7
2.8
0.32
254
1757
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
185
936
2.05
17.64
2.1
2.2
g/l
36.8
36.8
0.03
162
775
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
208
1101
1.96
17.46
2.1
2.4
g/l
3.1
3.2
0.35
177
850
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
213
1140
1.94
17.31
2.1
2.3
g/l
9.3
10.4
3.46
190
940
(3021879) Hepatitis B virus core Ab [Presence] in Serum
178
896
2.05
17.21
1.4
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
969
7576
1.43
16.67
3.8
3.1
mmol/l
6.2
6.8
5.77
789
6133
(3012516) Albumin [Mass/volume] in Urine
963
7561
1.42
16.02
3.8
3.2
mg/l
197.1
316.0
0.57
616
4810
(3049717) Cytology report of Urine Cyto stain
215
1189
1.88
15.82
2.9
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
649
4749
1.48
15.71
1.7
1.6
mg/l
2.0
1.5
0.90
501
3726
(3024354) Oxygen [Partial pressure] in Venous blood
360
2317
1.64
15.51
3.4
2.8
kpa
4.6
4.4
0.86
343
2231
(3005719) IgG [Mass/volume] in Serum or Plasma
248
1451
1.78
15.18
3.6
2.6
g/l
10.5
10.8
0.25
227
1293
(3020682) Albumin/Creatinine [Ratio] in Urine
1006
8027
1.40
14.99
4.8
3.9
mg/mmol
11.9
9.1
1.10
631
5047
(3024891) Influenza virus A+B Ag [Presence] in Specimen
110
485
2.32
14.83
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
122
564
2.22
14.70
2.2
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
564
4061
1.49
14.68
6.4
4.5
—
—
—
0
0
(3036489) Thrombin time
142
707
2.06
14.16
1.8
1.8
s
22.8
22.0
0.43
134
645
(3034860) Kappa light chains.free [Mass/volume] in Serum
190
1051
1.87
13.97
2.7
2.9
mg/l
84.1
112.0
0.19
147
864
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
810
6295
1.40
13.85
3.3
3.0
u/l
36.7
37.8
0.13
741
5902
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
186
1025
1.87
13.83
2.7
2.9
ratio
1.1
1.7
—
10
77
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
189
1049
1.86
13.75
2.8
2.9
mg/l
38.5
63.5
1.07
146
867
(3012501) Base excess in Blood by calculation
126
608
2.12
13.65
4.3
4.8
mmol/l
2.3
2.8
0.93
85
416
(3037522) Nuclear Ab [Titer] in Serum
341
2247
1.59
13.25
1.3
1.3
titre
464.7
563.4
0.41
68
534
(1616796) Gas panel - Central venous blood
128
630
2.08
13.18
4.7
3.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
142
728
2.00
13.08
1.7
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
346
2296
1.58
13.04
1.4
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
870
6905
1.38
12.94
4.8
5.0
%
22.5
22.2
0.22
446
3807
(3045142) Bone marrow Pathology biopsy report
73
284
2.61
12.92
1.2
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
814
6393
1.39
12.90
1.9
1.8
nmol/l
1154.0
1174.8
0.24
566
4689
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
32
74
4.36
12.86
2.2
2.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
26
51
5.14
12.68
1.9
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
592
4427
1.43
12.40
40.8
31.2
inr
1.6
1.5
0.08
62
581
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
73
290
2.56
12.39
1.9
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
426
3019
1.48
11.79
1.3
1.2
—
—
—
0
0
(3010421) pH of Blood
136
713
1.95
11.78
4.4
4.5
ph
7.4
7.4
0.14
122
591
(3028026) IgM [Mass/volume] in Serum or Plasma
194
1149
1.74
11.38
2.3
1.8
g/l
1.0
1.5
3.41
172
1004
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
85
378
2.29
11.31
1.3
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
129
678
1.95
11.11
3.2
2.2
g/l
123.5
126.2
0.54
86
488
(3011397) Hemoglobin [Presence] in Urine by Test strip
712
5587
1.37
11.05
4.3
4.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
89
412
2.20
10.77
6.7
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
92
441
2.12
10.22
1.9
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
624
4848
1.37
10.20
4.0
3.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
49
176
2.82
10.18
2.1
1.5
—
—
—
0
0
(3000492) Spirometry study
231
1482
1.61
10.00
2.1
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
100
500
2.04
9.94
2.0
2.1
%
88.9
87.1
0.33
94
477
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
17
28
6.10
9.92
13.8
13.4
mmol/l
7.5
5.5
0.39
17
28
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
80
368
2.21
9.86
2.5
2.0
pg
32.8
32.4
0.30
80
363
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
15
22
6.85
9.73
3.1
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
404
2935
1.44
9.73
1.3
1.3
iu/ml
45.3
41.6
0.13
106
896
(40767503) Oxygen content in Capillary blood by calculation
117
624
1.91
9.68
3.7
2.5
%
15.3
15.7
0.50
72
320
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
260
1746
1.54
9.24
1.5
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
72
327
2.23
9.18
4.6
3.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
486
3686
1.39
9.12
1.3
1.2
u/ml
1.0
1.6
1.54
89
890
(3001964) Herpes simplex virus Ag [Presence] in Specimen
23
54
4.29
9.12
2.4
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
90
449
2.04
9.03
1.4
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
75
350
2.17
8.96
1.9
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
333
2369
1.46
8.94
2.1
2.0
g/l
0.2
0.2
0.83
309
2166
(3036481) Cortisol [Moles/volume] in Serum or Plasma
277
1903
1.51
8.85
2.2
2.0
nmol/l
381.8
381.2
0.01
249
1706
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
111
601
1.88
8.80
1.8
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
70
322
2.20
8.67
1.8
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
40
141
2.86
8.64
3.3
2.0
min
500.4
489.8
0.39
29
96
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
159
965
1.69
8.58
1.2
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
23
6.11
8.18
5.1
4.8
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
51
211
2.44
8.07
3.0
2.2
ml
816.3
622.9
2.04
36
124
(3019420) Tryptase [Mass/volume] in Serum or Plasma
26
74
3.54
7.97
1.2
1.3
ug/l
5.5
10.7
1.69
26
64
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
161
1003
1.64
7.88
2.3
2.1
ug/l
345.7
768.9
1.21
151
938
(40768795) Lymph node Pathology biopsy report
49
202
2.45
7.82
1.2
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
94
502
1.90
7.81
1.6
1.5
g/l
29.3
30.7
0.50
78
453
(3012441) Differential panel - Pleural fluid
76
377
2.04
7.80
1.7
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
103
568
1.84
7.76
1.9
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
78
392
2.02
7.73
1.8
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
62
287
2.19
7.61
1.5
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
158
992
1.63
7.51
2.1
1.5
u/ml
20.6
18.7
—
8
23
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
53
231
2.32
7.50
1.1
1.1
u/ml
274.1
325.1
0.56
32
127
(3051611) Lipemic interference index of Serum or Plasma
62
290
2.16
7.42
3.7
3.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
130
782
1.69
7.29
1.6
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
94
516
1.85
7.21
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
96
533
1.83
7.10
1.5
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
270
1928
1.44
7.09
2.4
1.9
ug/g
151.4
157.3
0.07
204
1468
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
36
134
2.71
7.09
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
75
384
1.98
7.08
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
117
693
1.72
6.96
1.5
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
40
159
2.54
6.93
3.4
3.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
80
424
1.91
6.85
2.3
1.9
%
63.0
60.0
0.54
80
424
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
365
2770
1.37
6.73
1.2
1.2
u/ml
13.1
16.5
0.27
86
916
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
157
1013
1.58
6.70
2.4
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
146
927
1.61
6.66
3.7
2.8
g/l
0.4
0.3
0.44
65
337
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20
54
3.72
6.63
1.7
1.9
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
27
89
3.05
6.61
3.3
1.6
ug/l
62.6
55.3
0.12
27
84
(40760888) Immunoglobulin light chains.free panel - Serum
128
788
1.65
6.61
2.9
3.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1190
10507
1.23
6.59
4.9
4.5
ng/l
46.4
82.3
1.28
951
8420
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
84
3.11
6.58
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
35
134
2.63
6.55
1.5
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
388
2985
1.35
6.54
2.9
3.1
ng/l
340.1
257.9
1.97
353
2720
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
164
2.46
6.52
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
257
1851
1.43
6.45
3.2
2.9
ml/min/173m2
49.2
57.1
3.53
140
870
(3003694) ABO and Rh group [Type] in Blood
609
4999
1.28
6.40
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
90
507
1.80
6.39
1.6
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
250
2.14
6.27
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
29
103
2.83
6.26
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
679
5665
1.26
6.21
5.7
4.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
37
150
2.49
6.19
1.4
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
408
5147
0.76
6.18
6.0
5.0
kg/l
1.0
1.0
0.16
57
870
(36660697) Celiac disease serology panel - Serum
190
1303
1.49
6.16
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
29
106
2.75
5.95
2.3
2.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
36
147
2.47
5.94
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
67
352
1.93
5.93
1.7
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
75
410
1.85
5.89
1.7
1.4
e6/l
13059.0
71192.4
2.35
30
246
(3037692) Legionella sp identified in Specimen by Organism specific culture
23
74
3.13
5.89
2.5
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
92
537
1.74
5.82
1.5
1.4
g/l
1.1
1.2
0.37
87
512
(3000093) Morphology [Interpretation] in Blood Narrative
53
258
2.07
5.81
1.1
1.2
—
—
—
0
0
(3013512) EKG study
887
7671
1.23
5.80
5.1
4.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
81
456
1.80
5.79
1.3
1.2
u/l
32.0
46.3
0.82
69
395
(3021901) Oxygen saturation in Capillary blood
98
583
1.71
5.79
3.9
2.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
108
2.70
5.75
1.9
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
21
65
3.25
5.72
1.5
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
74
407
1.84
5.71
1.4
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
52
254
2.07
5.65
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
103
626
1.67
5.63
1.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
122
775
1.60
5.61
4.1
3.2
mmol/l
24.3
25.1
1.13
108
664
(3003181) Sodium [Moles/volume] in Urine
96
574
1.70
5.58
1.2
1.3
mmol/l
58.2
61.8
0.43
81
458
(3042631) Mycobacterium sp identified in Specimen
72
396
1.84
5.57
2.7
2.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
158
1066
1.51
5.56
1.5
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
59
304
1.96
5.55
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
102
623
1.66
5.49
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
45
213
2.13
5.33
1.2
1.2
u/l
68.6
59.9
0.39
34
140
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
230
1682
1.40
5.32
1.3
1.2
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
5
0
+∞
5.21
7.0
0.0
ug/l
9.4
—
—
5
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
111
703
1.60
5.19
1.4
1.5
ug/g
279.6
261.9
0.42
65
432
(3004809) Band form neutrophils/100 leukocytes in Blood
77
444
1.75
5.12
6.1
3.9
%
1.2
1.6
0.47
62
329
(42529406) Shigella sp [Presence] in Stool by Culture
101
628
1.63
5.09
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
27
104
2.61
5.05
1.7
1.8
e6/l
460.0
619.3
—
9
51
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
19
60
3.18
5.04
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
380
3023
1.30
5.03
3.3
3.7
ug/l
35.2
23.6
0.30
293
2522
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
37
166
2.25
5.01
1.3
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
37
166
2.25
5.01
1.3
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
21
71
2.97
4.98
2.1
1.5
g/l
0.8
0.9
0.74
21
71
(3011412) CD3 cells [#/volume] in Blood
35
155
2.27
4.89
1.9
1.8
e9/l
1.1
1.0
0.35
23
91
(3028626) Oxygen [Partial pressure] in Capillary blood
106
675
1.59
4.87
4.0
2.9
kpa
8.0
7.7
1.48
99
623
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
206
1515
1.39
4.64
2.6
2.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
111
725
1.55
4.59
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
257
3322
0.75
4.57
11.3
8.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
45
227
2.00
4.55
1.6
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
412
3356
1.27
4.52
5.6
5.7
kpa
5.0
5.1
1.47
390
3163
(3023199) Leukocytes [#/volume] in Pleural fluid
75
447
1.70
4.48
1.7
1.4
e6/l
691.7
2003.7
4.18
38
327
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
60
336
1.80
4.45
6.6
5.9
mg/l
12.2
12.7
0.43
51
304
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
65
2.94
4.44
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
135
927
1.48
4.43
3.6
3.2
nmol/l
0.8
0.8
0.37
109
700
(3027801) Oxygen [Partial pressure] in Arterial blood
411
3355
1.26
4.43
5.6
5.7
kpa
12.3
11.7
1.40
388
3161
(3008295) Osmolality of Serum or Plasma
50
265
1.90
4.40
1.4
1.3
mosm/kgh2o
282.8
273.5
1.53
38
179
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
105
688
1.55
4.30
1.4
1.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
26
107
2.44
4.30
1.2
1.4
%
0.3
3.4
—
6
25
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
57
318
1.81
4.29
1.4
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
38
185
2.07
4.25
1.2
1.2
u/ml
2.2
5.1
1.62
18
90
(3004716) Salmonella sp identified in Stool by Organism specific culture
108
718
1.52
4.15
1.3
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
21
79
2.67
4.15
1.8
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
32
148
2.18
4.08
4.2
3.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
97
634
1.55
4.04
1.2
1.2
u/ml
1.2
1.0
—
5
62
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
87
2.54
3.96
1.1
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
848
7536
1.18
3.84
2.7
2.5
u/l
62.6
58.1
0.47
766
6863
(21494434) Karyotype in Bone marrow
47
257
1.84
3.81
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
405
3361
1.24
3.77
5.7
5.7
mmol/l
0.4
1.2
2.87
322
2553
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
184
1377
1.36
3.77
2.9
2.4
%
0.7
0.7
0.01
175
1317
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
84
2.51
3.71
1.1
1.1
—
—
—
0
0
(44790047)
45
245
1.85
3.70
2.0
1.4
—
—
—
0
0
(44790048)
45
245
1.85
3.70
2.0
1.4
—
—
—
0
0
(44806118)
45
245
1.85
3.70
2.0
1.4
—
—
—
0
0
(44790049)
45
245
1.85
3.70
2.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
80
512
1.58
3.68
1.7
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
37
190
1.96
3.63
1.2
1.2
u/ml
1.9
4.0
0.72
15
62
(3036525) Urea [Moles/time] in 24 hour Urine
7
9
7.79
3.56
3.3
3.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
46
3.05
3.52
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
62
377
1.66
3.51
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
40
214
1.88
3.49
1.2
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
38
200
1.91
3.48
1.1
1.2
mmol/l
32.7
34.7
0.21
30
170
(40768441) Liver Pathology biopsy report
27
125
2.17
3.48
1.3
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
139
1009
1.40
3.45
2.8
2.9
u/ml
4747.5
5108.8
0.04
120
851
(3017446) Testosterone [Moles/volume] in Serum or Plasma
159
1182
1.37
3.42
2.2
2.1
nmol/l
11.5
11.0
0.21
124
992
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
59
357
1.67
3.42
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
55
882
0.62
3.21
5.5
5.6
mmol/l
1.5
1.3
0.31
48
782
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
137
1006
1.38
3.20
2.8
3.0
pmol/l
4.3
4.3
0.02
115
849
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
22
97
2.28
3.19
1.0
1.1
—
—
—
0
0
(3025315) Body weight
8
15
5.35
3.19
7.6
5.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
15
5.35
3.19
1.6
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
130
2.09
3.18
1.2
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
48
282
1.71
3.12
5.0
3.8
%
55.1
58.8
0.32
28
174
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
49
290
1.70
3.11
1.3
1.5
%
70.0
63.5
0.50
30
194
(3044927) Protein electrophoresis panel - Urine
56
344
1.64
3.09
1.1
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
8
7.51
3.05
3.7
5.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
91
627
1.47
3.04
1.7
1.6
e6/l
12866.5
16784.6
0.54
59
455
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
27
133
2.04
3.01
1.5
1.5
u/l
4.1
6.8
0.56
14
62
(40757373) Influenza virus identified in Isolate
18
75
2.41
2.96
2.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
51
311
1.65
2.92
1.0
1.1
—
—
—
0
0
(4306422)
31
163
1.91
2.90
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
147
1915
0.75
2.81
6.1
6.0
mmol/l
23.8
24.5
1.28
136
1786
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
18
4.45
2.79
1.8
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
150
1145
1.33
2.77
2.4
2.5
au/ml
15.1
29.0
—
5
23
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
26
131
1.99
2.75
1.4
2.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
7
14
5.01
2.73
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
48
295
1.64
2.69
7.8
4.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
214
1720
1.26
2.68
4.8
3.7
mmol/l
1.9
2.1
0.29
160
1247
(3023410) Appearance of Cerebral spinal fluid
29
154
1.89
2.65
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
23
113
2.04
2.61
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
23
113
2.04
2.61
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
23
113
2.04
2.61
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
23
113
2.04
2.61
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
46
282
1.64
2.61
2.8
2.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
41
244
1.69
2.60
1.2
1.5
g/l
0.7
0.9
0.65
26
186
(3023419) Bacteria identified in Sputum by Culture
55
353
1.57
2.59
3.2
2.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
31
170
1.83
2.58
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
50
314
1.60
2.58
1.3
1.4
—
—
—
0
0
(4010399)
199
1594
1.27
2.58
1.6
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
23
114
2.03
2.56
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
23
114
2.03
2.56
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
23
114
2.03
2.56
1.1
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
223
1815
1.25
2.52
3.8
3.0
g/l
122.4
125.6
1.44
213
1773
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
222
1810
1.25
2.48
4.9
3.7
kpa
5.1
5.2
0.23
207
1642
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
49
310
1.59
2.47
1.3
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
219
1785
1.25
2.45
5.0
3.7
ph
7.4
7.4
0.12
55
214
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
212
1724
1.25
2.43
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
49
312
1.58
2.41
1.3
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
28
153
1.84
2.38
1.9
2.2
ug/min
57.6
103.1
—
8
35
(3029937) Albumin [Presence] in Urine by Test strip
687
6210
1.14
2.33
6.1
4.8
estimate
0.0
0.0
0.00
321
1896
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
25
133
1.89
2.31
1.6
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
25
133
1.89
2.31
1.6
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
25
133
1.89
2.31
1.6
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
25
133
1.89
2.31
1.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
48
308
1.57
2.30
1.4
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
20
99
2.03
2.26
1.4
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
29
3.11
2.22
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
48
311
1.55
2.22
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
207
1700
1.24
2.19
1.5
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
107
811
1.33
2.14
2.1
1.7
u/l
40.7
38.5
0.38
88
671
(3005322) IgE [Units/volume] in Serum or Plasma
111
849
1.32
2.09
1.2
1.3
u/ml
122.8
203.2
0.78
102
763
(3004451) EKG impression Narrative
27
153
1.77
2.08
1.1
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
10
5.01
2.07
3.4
2.7
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
75
541
1.40
2.05
1.3
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
20
3.51
2.05
1.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
48
318
1.52
2.03
1.4
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
12
50
2.41
2.02
1.3
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
32
2.82
2.00
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
344
2991
1.17
1.99
6.2
6.0
%
96.0
95.2
2.81
333
2861
(4268621)
24
133
1.81
1.99
2.1
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
142
1768
0.79
1.98
3.2
3.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
313
2704
1.18
1.97
6.6
6.3
g/l
115.2
118.9
3.25
305
2601
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
258
3021
0.84
1.96
5.1
4.9
%
35.2
34.1
0.78
179
1875
(3024522) Salmonella sp identified in Specimen by Organism specific culture
47
313
1.51
1.96
1.4
1.4
—
—
—
0
0
(4062490)
26
149
1.75
1.94
1.1
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
663
6046
1.13
1.94
1.8
1.8
pmol/l
472.1
12273064.2
2.48
504
4783
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
16
3.76
1.93
1.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
45
2.45
1.93
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
33
203
1.63
1.92
1.1
1.1
u/ml
—
—
—
0
0
(3000012) Reticulocyte production index
28
165
1.70
1.91
2.1
1.4
—
—
—
0
0
(4034850)
52
744
0.69
1.88
12.9
13.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
18
93
1.94
1.85
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
302
0.53
1.82
1.4
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
101
1.89
1.80
1.8
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
101
1.89
1.80
1.8
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
44
296
1.49
1.77
1.4
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
322
2814
1.16
1.77
2.4
2.5
ug/l
6.1
6.4
0.13
273
2330
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
37
240
1.55
1.76
1.5
1.4
u/l
13.6
14.2
0.19
37
226
(3020650) Glucose [Presence] in Urine
10
41
2.44
1.75
1.3
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
127
1016
1.26
1.75
2.3
2.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
35
227
1.55
1.67
1.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
104
1.83
1.67
1.8
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
379
0.60
1.64
1.1
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
14
3.58
1.61
1.0
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
166
1.63
1.61
1.1
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
19
106
1.80
1.58
1.3
1.3
ug/l
425.6
306.5
—
10
57
(3039443) Prostate specific Ag panel - Serum or Plasma
11
222
0.49
1.57
1.6
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
74
561
1.33
1.56
1.3
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
30
192
1.57
1.54
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
49
348
1.42
1.53
1.3
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
27
2.60
1.51
1.6
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
146
1.65
1.50
1.1
1.3
g/l
2.2
2.8
0.67
15
108
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
146
1.65
1.50
1.1
1.3
g/l
7.0
7.4
0.13
15
106
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
146
1.65
1.50
1.1
1.3
g/l
0.5
0.4
0.15
13
108
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
36
242
1.49
1.49
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
26
162
1.61
1.49
1.4
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
42
594
0.70
1.48
4.4
3.9
mg/l
32.1
28.9
0.20
25
398
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
33
218
1.52
1.48
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
33
218
1.52
1.48
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
33
218
1.52
1.48
1.6
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
105
841
1.26
1.47
1.1
1.1
iu/ml
120.9
121.8
0.01
29
284
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
38
2.37
1.45
1.4
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
153
1282
1.20
1.42
1.3
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
88
1.82
1.41
3.2
2.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
157
1.60
1.40
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
26
165
1.58
1.40
2.2
2.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
83
651
1.28
1.39
3.6
2.3
ug/min
202.8
80.5
0.79
52
370
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
74
1.90
1.39
1.1
1.1
u/l
1.3
1.3
—
8
40
(3007566) Smooth muscle Ab [Titer] in Serum
61
459
1.34
1.38
1.1
1.1
titre
176.0
88.1
—
5
26
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
49
356
1.38
1.38
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
247
1.46
1.37
1.1
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
20
119
1.69
1.37
1.1
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
154
1298
1.20
1.35
1.6
1.8
ug/l
2.8
2.5
0.06
132
1095
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
82
1.83
1.35
1.1
1.2
—
—
—
0
0
(4146454)
20
322
0.62
1.35
3.0
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
60
453
1.33
1.33
1.3
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
18
105
1.72
1.33
1.4
1.6
—
10.5
—
0
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
24
2.50
1.30
1.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
194
1.50
1.26
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
171
1466
1.18
1.26
7.9
7.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
47
346
1.36
1.24
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
49
2.04
1.22
1.1
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
37
2.17
1.21
1.4
1.1
—
—
—
0
0
(4211845)
7
144
0.48
1.20
5.4
4.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
82
657
1.26
1.20
1.7
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
70
550
1.28
1.20
1.8
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
147
1251
1.18
1.19
2.4
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
332
1.36
1.19
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
79
1.78
1.17
1.5
2.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
32
223
1.44
1.16
1.4
1.4
%
17.3
26.0
0.87
16
142
(3045424) Erythrocytes [Presence] in Urine
46
342
1.35
1.16
2.2
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
174
1.50
1.15
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
40
2.00
1.12
1.0
1.1
miu/ml
2511.8
1551.2
—
8
40
(3009214) Lutropin [Units/volume] in Serum or Plasma
30
209
1.44
1.10
1.5
1.2
u/l
12.5
10.7
0.19
15
158
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
31
2.26
1.10
1.4
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
31
2.26
1.10
1.4
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
96
1.67
1.10
1.1
1.1
u/ml
1.1
1.0
—
6
35
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
480
0.73
1.10
1.4
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
136
0.51
1.09
5.4
4.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
160
1.50
1.09
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
160
1.50
1.09
2.7
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
30
210
1.43
1.08
1.3
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
35
253
1.39
1.06
1.7
1.6
u/ml
13.2
25.1
—
9
58
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
47
1.92
1.02
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
892
8491
1.07
1.01
6.2
4.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
48
1.88
1.00
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
21
139
1.51
1.00
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
21
139
1.51
1.00
1.3
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
7
35
2.00
1.00
1.0
1.0
umol/l
19.2
16.6
—
7
29
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
107
1263
0.84
0.99
4.4
4.5
%
1.4
1.6
1.16
102
1189
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
131
1.53
0.99
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
135
1162
1.17
0.99
2.2
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
275
1.35
0.97
1.3
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
36
1.95
0.97
1.3
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
59
470
1.26
0.95
1.3
1.2
u/ml
4.9
6.2
—
10
81
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
37
1.89
0.94
1.9
2.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
58
462
1.26
0.94
1.3
1.2
u/ml
1.6
4.5
—
5
49
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
93
1.62
0.93
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
391
1.28
0.93
1.2
1.3
e6/l
27.0
33.0
0.11
36
314
(3024932) HLA-DR beta [Type]
6
27
2.22
0.93
1.2
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
35
260
1.35
0.93
4.1
3.2
nmol/l
9.5
5.8
0.54
30
255
(3007930) Methemoglobin/Hemoglobin.total in Blood
107
1253
0.85
0.92
4.4
4.5
%
0.9
0.9
0.25
102
1181
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
66
535
1.24
0.92
1.4
1.5
iu/ml
0.5
11.3
0.66
18
140
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
50
392
1.28
0.92
1.4
1.4
e6/l
1574.0
907.8
0.40
39
329
(3024471) HLA-A [Type]
6
28
2.15
0.91
1.2
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
78
1.67
0.91
4.9
2.1
u/ml
2568.5
110446.7
—
6
12
(40768793) Breast Pathology biopsy report
57
456
1.26
0.90
1.2
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
32
237
1.35
0.87
1.2
1.3
nmol/l
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
21
144
1.46
0.87
2.0
1.9
u/field
2.3
2.7
0.20
16
92
(3017732) Neutrophils [#/volume] in Blood
154
1356
1.14
0.87
3.1
3.3
e9/l
4.1
4.4
0.51
95
919
(3005570) Glucose [Moles/volume] in Urine
38
290
1.31
0.86
2.4
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
139
0.57
0.83
1.5
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
11
65
1.70
0.82
1.8
1.7
pmol/l
18.2
15.6
—
6
49
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
55
444
1.24
0.82
1.1
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
73
1.65
0.81
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
31
232
1.34
0.81
1.5
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
29
215
1.35
0.80
1.5
1.5
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
24
0.00
0.79
0.0
1.9
—
2.6
—
0
19
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
32
242
1.33
0.78
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
304
1.29
0.78
1.4
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
10
59
1.70
0.75
1.6
1.5
ug/l
0.7
0.4
—
5
31
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
53
1.70
0.75
2.6
1.9
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
38
1.84
0.73
1.9
2.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
76
1.58
0.71
1.2
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
40
1.75
0.71
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
58
1.55
0.69
1.2
1.3
—
—
—
0
0
(4281824)
30
230
1.31
0.69
1.1
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
121
0.58
0.67
1.3
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
7
43
1.63
0.66
3.7
2.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
14
94
1.49
0.66
1.0
1.1
nmol/l
130.4
137.9
0.25
14
94
(3026480) Teichoate Ab [Titer] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
111
1.44
0.66
1.0
1.2
mmol/l
11.4
11.7
—
9
37
(3027923) C peptide [Moles/volume] in Serum or Plasma
16
111
1.44
0.66
1.2
1.3
nmol/l
1.0
1.0
0.07
11
80
(3043409) Potassium [Moles/volume] in Arterial blood
80
926
0.86
0.65
3.9
3.5
mmol/l
4.0
3.9
1.16
74
851
(3035880) pH of Pleural fluid
28
216
1.30
0.63
1.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
34
270
1.26
0.62
1.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
49
1.63
0.62
2.1
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
176
0.68
0.61
1.6
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
20
0.00
0.60
0.0
12.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
209
1.29
0.60
1.6
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
39
318
1.23
0.58
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
47
392
1.20
0.57
1.2
1.2
mmol/l
4.2
4.0
0.38
41
359
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
115
1.39
0.56
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
47
393
1.20
0.56
1.2
1.6
iu/l
12.6
4.7
—
10
117
(3034426) Prothrombin time (PT)
6
38
1.58
0.54
1.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
60
1.50
0.54
1.1
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
68
591
1.15
0.53
2.5
2.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
100
1.40
0.51
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
83
1.45
0.51
1.0
1.0
u/ml
6.1
2.2
—
6
30
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
83
1.45
0.51
1.0
1.0
u/ml
0.8
0.8
—
5
31
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
9
136
0.66
0.51
4.6
5.1
—
41.7
—
0
36
(3006270) Folate [Moles/volume] in Blood
21
269
0.78
0.50
1.0
1.2
nmol/l
365.6
315.5
0.44
16
210
(3013727) Leukocytes other/100 leukocytes in Blood
13
93
1.40
0.48
9.3
3.9
%
45.5
54.2
0.69
13
87
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
29
235
1.24
0.48
1.1
1.1
iu/ml
1.0
55.5
—
5
44
(3019225) pH of Specimen
266
2823
0.94
0.46
6.6
4.6
—
—
—
0
0
(4024509)
35
291
1.21
0.46
1.8
1.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
94
1.38
0.46
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
138
1.31
0.45
1.4
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
135
1240
1.09
0.44
1.5
1.5
%
1.5
1.6
1.51
98
994
(3033705) Calcium.ionized [Moles/volume] in Venous blood
52
451
1.16
0.44
3.0
2.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
78
1.41
0.43
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
78
1.41
0.43
1.1
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
42
359
1.17
0.42
3.4
3.9
u/ml
24.4
44.3
1.43
42
349
(3014271) Vancomycin [Susceptibility]
27
221
1.22
0.42
3.5
3.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
32
1.56
0.42
1.4
1.9
—
—
—
0
0
(4212803)
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
10
139
0.72
0.42
1.2
1.7
mmol/l
7.8
9.3
—
10
114
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
59
1.36
0.41
1.5
1.5
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
17
0.00
0.40
0.0
1.1
—
10.1
—
0
10
(3015183) Erythrocyte sedimentation rate
5
34
1.47
0.40
1.4
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
105
0.67
0.39
6.6
5.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
11
80
1.38
0.38
1.7
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
26
215
1.21
0.38
1.2
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
89
1.35
0.38
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
89
1.35
0.38
1.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
52
458
1.14
0.37
3.0
2.4
mmol/l
105.7
105.4
0.18
52
453
(3041354) Potassium [Moles/volume] in Venous blood
52
458
1.14
0.37
3.0
2.4
mmol/l
4.1
4.1
0.12
52
453
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.2
1.5
umol/l
50.2
40.8
—
5
37
(3032773) Endomysium IgG Ab [Titer] in Serum
16
125
1.28
0.37
1.1
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
20
245
0.82
0.36
1.5
1.2
e6/l
95230.0
177008.2
0.34
11
165
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
26
218
1.19
0.34
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
35
302
1.16
0.34
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
243
0.82
0.33
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
109
1.29
0.33
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
46
1.30
0.33
2.0
1.7
ng/l
207.0
132.3
—
6
46
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
52
1.35
0.31
1.7
1.5
ug/l
7.3
9.4
—
7
52
(3019060) Gas panel - Arterial blood
194
2039
0.95
0.29
3.9
4.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
20
167
1.20
0.28
1.0
1.1
—
4.7
—
0
7
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
167
1.20
0.28
1.5
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
135
1271
1.07
0.28
5.1
3.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
13
103
1.26
0.28
1.5
1.3
u/ml
0.0
2.0
—
7
63
(3040151) Glucose [Moles/volume] in Capillary blood
41
365
1.13
0.27
4.2
6.5
mmol/l
6.5
7.5
1.75
35
303
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
65
1.23
0.27
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
65
1.23
0.27
1.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
67
1.19
0.26
2.3
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
18
152
1.19
0.23
1.6
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(44813793)
7
91
0.77
0.22
1.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
7
93
0.75
0.22
1.0
1.2
mmol/l
6.3
6.3
—
7
88
(40758358) Immune stain study
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
11
0.00
0.21
0.0
1.7
—
4.6
—
0
11
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.1
—
4.4
—
0
6
(3020891) Body temperature
113
1191
0.95
0.21
5.2
4.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
43
1.16
0.21
1.4
1.3
%
116.2
116.1
—
5
38
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
221
2287
0.96
0.20
5.3
3.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
384
1.10
0.20
2.3
1.3
nmol/l
0.8
0.8
0.04
36
300
(44806420)
14
118
1.19
0.19
2.7
2.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
52
1.15
0.19
8.8
6.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
81
1.24
0.18
1.4
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
58
1.21
0.18
1.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
20
176
1.14
0.17
1.5
2.9
mmol/l
8.9
7.1
0.89
11
113
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
224
1.12
0.17
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
129
1.16
0.17
1.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
70
0.71
0.16
1.0
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
16
183
0.87
0.16
3.1
16.2
—
—
—
0
0
(4027681)
8
71
1.13
0.16
1.4
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
72
1.11
0.16
1.3
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
9
80
1.13
0.15
2.9
2.0
mmol/l
1.1
1.1
—
9
74
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
86
0.81
0.14
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
275
0.91
0.14
2.4
2.2
u/field
1.0
2.0
1.18
12
80
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
141
1.14
0.14
8.9
3.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
20
180
1.11
0.13
1.0
1.1
—
66.7
—
0
7
(3026389) Candida sp identified in Specimen by Organism specific culture
28
304
0.92
0.13
1.1
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
104
1.15
0.12
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
104
1.15
0.12
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
280
0.93
0.10
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
96
1.15
0.10
1.1
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
44
1.14
0.10
1.4
1.2
g/l
0.3
0.3
—
5
32
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
5
45
1.11
0.09
1.2
1.3
%
69.7
76.8
—
5
37
(3024869) Neuronal Ab [Presence] in Serum
5
45
1.11
0.09
1.2
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
5
48
1.04
0.09
1.0
1.0
%
82.4
99.0
—
5
31
(3029075) Extractable nuclear Ab panel - Serum
6
56
1.07
0.08
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
65
0.77
0.08
6.2
2.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
88
905
0.97
0.07
7.5
4.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
75
1.07
0.07
1.0
1.2
—
—
—
0
0
(4015189)
7
81
0.86
0.07
1.1
1.9
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
8
91
0.88
0.06
1.6
1.4
%
31.0
22.5
—
8
72
(3019977) pH of Arterial blood
17
183
0.93
0.06
1.4
2.2
ph
7.4
7.4
0.86
11
63
(3038026) Centromere Ab [Units/volume] in Serum
20
187
1.07
0.06
1.0
1.2
—
54.9
—
0
6
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
254
0.94
0.06
1.4
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
40
385
1.04
0.05
1.7
2.4
mg/l
17.1
25.3
0.88
15
82
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
17
159
1.07
0.05
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
258
1.05
0.04
1.0
1.2
—
—
—
0
0
(4094501)
51
498
1.02
0.03
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
156
1544
1.01
0.03
6.0
4.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
17
179
0.95
0.03
2.5
2.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
14
145
0.97
0.00
1.3
1.1
mmol/l
2.0
2.1
0.26
14
133
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
107
1075
1.00
0.00
5.6
4.1
mmol/l
25.1
24.9
0.17
99
968
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
96
1.04
0.00
1.7
1.5
nmol/l
9.6
15.2
—
10
86
(3009466) Valproate [Moles/volume] in Serum or Plasma
26
258
1.01
0.00
3.4
3.6
umol/l
305.0
333.9
0.54
26
218
(3032057) Clostridioides difficile [Presence] in Stool
7
73
0.96
0.00
1.9
1.7
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.4
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_SKIN_FACE – Carcinoma in situ of skin of other and unspecified parts of face

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).